{"id":"https://openalex.org/W2398887385","doi":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","title":"Generic substitution of commonly used medications: Australia\u2010wide experience, 2007\u20132008","display_name":"Generic substitution of commonly used medications: Australia\u2010wide experience, 2007\u20132008","publication_year":2010,"publication_date":"2010-04-01","ids":{"openalex":"https://openalex.org/W2398887385","doi":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","mag":"2398887385","pmid":"https://pubmed.ncbi.nlm.nih.gov/20367581"},"language":"en","primary_location":{"id":"doi:10.5694/j.1326-5377.2010.tb03556.x","doi":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","is_oa":false,"landing_page_url":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","pdf_url":null,"source":{"id":"https://openalex.org/S13978405","display_name":"The Medical Journal of Australia","issn_l":"0025-729X","issn":["0025-729X","1326-5377"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Australia","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067187613","display_name":"Michael S. Ortiz","orcid":"https://orcid.org/0000-0003-0183-9273","observed_orcids":["https://orcid.org/0000-0003-0183-9273"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michael Ortiz","raw_affiliation_strings":["Solvay Pharmaceuticals, Sydney, NSW","University of New South Wales, St Vincent's Hospital, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Solvay Pharmaceuticals, Sydney, NSW","institution_ids":[]},{"raw_affiliation_string":"University of New South Wales, St Vincent's Hospital, Sydney, NSW","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4210087284"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103174255","display_name":"Leon A. Simons","orcid":"https://orcid.org/0000-0001-8082-6416","observed_orcids":["https://orcid.org/0000-0001-8082-6416"]},"institutions":[{"id":"https://openalex.org/I31746571","display_name":"UNSW Sydney","ror":"https://ror.org/03r8z3t63","country_code":"AU","type":"education","lineage":["https://openalex.org/I31746571"]},{"id":"https://openalex.org/I4210087284","display_name":"St Vincent's Hospital Sydney","ror":"https://ror.org/000ed3w25","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210087284"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"Leon A Simons","raw_affiliation_strings":["University of New South Wales, St Vincent's Hospital, Sydney, NSW"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of New South Wales, St Vincent's Hospital, Sydney, NSW","institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4210087284"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5005938708","display_name":"Gordon Calcino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gordon Calcino","raw_affiliation_strings":["HI Connections Pty Ltd, Canberra, ACT"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"HI Connections Pty Ltd, Canberra, ACT","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5103174255"],"corresponding_institution_ids":["https://openalex.org/I31746571","https://openalex.org/I4210087284"],"apc_list":{"value":3400,"currency":"USD","value_usd":3400},"apc_paid":null,"fwci":2.0654,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.91149022,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"192","issue":"7","first_page":"370","last_page":"373"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10391","display_name":"Healthcare Policy and Management","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generic-substitution","display_name":"generic substitution","score":0.875},{"id":"https://openalex.org/keywords/brand-switching","display_name":"brand switching","score":0.8799999952316284},{"id":"https://openalex.org/keywords/pharmaceutical-benefits-scheme","display_name":"Pharmaceutical Benefits Scheme","score":0.7450000047683716},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9509999752044678},{"id":"https://openalex.org/keywords/calcium-channel-blockers","display_name":"calcium channel blockers","score":0.9549999833106995},{"id":"https://openalex.org/keywords/selective-serotonin-reuptake-inhibitors","display_name":"selective serotonin reuptake inhibitors","score":0.9829999804496765},{"id":"https://openalex.org/keywords/prescription-drug-reimbursement","display_name":"prescription drug reimbursement","score":0.3160000145435333},{"id":"https://openalex.org/keywords/patient-confusion","display_name":"patient confusion","score":0.625},{"id":"https://openalex.org/keywords/pravastatin","display_name":"pravastatin","score":0.7919999957084656},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":0.9409999847412109},{"id":"https://openalex.org/keywords/amlodipine","display_name":"amlodipine","score":0.9769999980926514},{"id":"https://openalex.org/keywords/felodipine","display_name":"felodipine","score":0.9409999847412109},{"id":"https://openalex.org/keywords/nifedipine","display_name":"nifedipine","score":0.9959999918937683},{"id":"https://openalex.org/keywords/fluoxetine","display_name":"fluoxetine","score":0.9390000104904175},{"id":"https://openalex.org/keywords/fluvoxamine","display_name":"fluvoxamine","score":0.8849999904632568},{"id":"https://openalex.org/keywords/paroxetine","display_name":"paroxetine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":1.0}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7164794206619263},{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.5423924922943115},{"id":"https://openalex.org/C2779910183","wikidata":"https://www.wikidata.org/wiki/Q409236","display_name":"Fluvoxamine","level":5,"score":0.5373659729957581},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.4689347743988037},{"id":"https://openalex.org/C23276603","wikidata":"https://www.wikidata.org/wiki/Q158230","display_name":"Pharmacoepidemiology","level":3,"score":0.4672315716743469},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.46188443899154663},{"id":"https://openalex.org/C2778793514","wikidata":"https://www.wikidata.org/wiki/Q7180724","display_name":"Pharmaceutical Benefits Scheme","level":3,"score":0.46070021390914917},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.41446760296821594},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3965582847595215},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39059364795684814},{"id":"https://openalex.org/C2776134451","wikidata":"https://www.wikidata.org/wiki/Q422244","display_name":"Fluoxetine","level":4,"score":0.3421584367752075},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.21206814050674438},{"id":"https://openalex.org/C2775864247","wikidata":"https://www.wikidata.org/wiki/Q167934","display_name":"Serotonin","level":3,"score":0.10457709431648254},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001315","descriptor_name":"Australia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002121","descriptor_name":"Calcium Channel Blockers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055656","descriptor_name":"Prescriptions","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.5694/j.1326-5377.2010.tb03556.x","doi":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","is_oa":false,"landing_page_url":"https://doi.org/10.5694/j.1326-5377.2010.tb03556.x","pdf_url":null,"source":{"id":"https://openalex.org/S13978405","display_name":"The Medical Journal of Australia","issn_l":"0025-729X","issn":["0025-729X","1326-5377"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Medical Journal of Australia","raw_type":"journal-article"},{"id":"pmid:20367581","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20367581","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Medical journal of Australia","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":15,"referenced_works":["https://openalex.org/W1564032779","https://openalex.org/W1989247444","https://openalex.org/W2021418434","https://openalex.org/W2057124956","https://openalex.org/W2059211690","https://openalex.org/W2067844263","https://openalex.org/W2122522597","https://openalex.org/W2140329113","https://openalex.org/W2165103822","https://openalex.org/W2263622592","https://openalex.org/W2321991445","https://openalex.org/W2395357059","https://openalex.org/W2409534060","https://openalex.org/W2411951338","https://openalex.org/W4285719527"],"related_works":["https://openalex.org/W2067844263","https://openalex.org/W2165103822","https://openalex.org/W2078857621","https://openalex.org/W2043901040","https://openalex.org/W2098426702","https://openalex.org/W2107837676","https://openalex.org/W3041814658","https://openalex.org/W2108245053","https://openalex.org/W4389507009","https://openalex.org/W2434870636"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"study":[2,154],"the":[3,19,56,146,153],"extent":[4],"of":[5,15,29,55,89,172,240],"brand":[6,95,103,151],"substitution":[7,230],"and":[8,74,97,138,162,179,197],"switching":[9,167,202],"in":[10,236,267],"three":[11,187],"commonly":[12],"used":[13],"classes":[14,62,212],"drugs":[16],"available":[17],"on":[18],"Pharmaceutical":[20],"Benefits":[21],"Scheme":[22],"(PBS).":[23],"DESIGN,":[24],"SETTING":[25],"AND":[26],"PARTICIPANTS:":[27],"Assessment":[28],"PBS":[30],"claim":[31],"records":[32],"for":[33,45,114,126,157,160,164,170,192,195,199,209,214,222,251],"a":[34,51,127,237],"1-year":[35],"period":[36],"from":[37,50],"1":[38],"August":[39],"2007":[40],"to":[41,110,255],"31":[42],"July":[43],"2008":[44],"long-term":[46],"concession":[47],"cardholders":[48],"drawn":[49],"10%":[52,194],"random":[53],"sample":[54],"Australian":[57],"population.":[58],"The":[59,249],"target":[60],"drug":[61,211],"were:":[63],"statins":[64],"(pravastatin,":[65],"simvastatin),":[66],"calcium":[67],"channel":[68],"blockers":[69],"(CCBs)":[70],"(amlodipine,":[71],"felodipine,":[72],"nifedipine),":[73],"selective":[75],"serotonin":[76],"reuptake":[77],"inhibitor":[78],"(SSRI)":[79],"antidepressants":[80],"(fluoxetine,":[81],"fluvoxamine,":[82],"paroxetine,":[83],"sertraline).":[84],"MAIN":[85],"OUTCOME":[86],"MEASURES:":[87],"Proportion":[88],"patients":[90,120,131,147,173,208,241],"who":[91],"were":[92],"non-switchers":[93],"(single":[94],"only)":[96],"multiple":[98,232],"switchers":[99],"(two":[100],"or":[101,188,247],"more":[102,189,204],"switches).":[104],"RESULTS:":[105],"We":[106],"retrieved":[107],"information":[108],"relating":[109],"935":[111],"334":[112],"prescriptions":[113,125],"122":[115],"000":[116],"patients.":[117],"Of":[118],"those":[119,215,223],"filling":[121],"at":[122],"least":[123],"four":[124],"product,":[128],"41":[129],"174":[130],"received":[132,136,141,148],"statins,":[133,158,175,193,245],"27":[134],"230":[135],"CCBs":[137,246],"21":[139],"342":[140],"SSRIs.":[142,165,200,248],"More":[143],"than":[144],"half":[145],"only":[149],"one":[150],"during":[152],"period:":[155],"57%":[156],"60%":[159],"CCBs,":[161,178,196],"63%":[163],"Multiple":[166,201],"was":[168,203],"recorded":[169],"24%":[171],"with":[174,177,181,183,231,244,263],"19%":[176],"21%":[180],"SSRIs,":[182],"smaller":[184],"proportions":[185],"receiving":[186],"brands:":[190],"14%":[191],"12%":[198],"common":[205],"among":[206],"younger":[207],"all":[210],"(28%":[213],"aged":[216,224],"<":[217],"50":[218],"years":[219],"v":[220],"18%":[221],">/=":[225],"80":[226],"years).":[227],"CONCLUSION:":[228],"Generic":[229],"switches":[233],"is":[234],"occurring":[235],"small":[238],"proportion":[239],"being":[242],"treated":[243],"potential":[250],"patient":[252],"confusion":[253],"appears":[254],"be":[256],"relatively":[257],"small,":[258],"but":[259],"this":[260],"may":[261],"change":[262],"recent":[264],"incentives":[265],"included":[266],"pharmacy":[268],"reimbursement":[269],"arrangements.":[270]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}